133 related articles for article (PubMed ID: 1336265)
1. [The effect of ethanol on the motor activity of rats and on the content of GABA and dopamine and its metabolites in the nigrostriatal system].
Karpova IV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(5):1027-30. PubMed ID: 1336265
[No Abstract] [Full Text] [Related]
2. [The effect of glutamate on the dopamine content and metabolism in the nigrostriatal system of rats differing by their learning capacities].
Karpova IV; Iakimovskiĭ AF
Fiziol Zh Im I M Sechenova; 1993 Feb; 79(2):43-51. PubMed ID: 8101122
[TBL] [Abstract][Full Text] [Related]
3. [The content of dopamine, its metabolites and GABA in the nigrostriatal system of rats with different learning abilities].
Karpova IV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(1):161-3. PubMed ID: 1316006
[No Abstract] [Full Text] [Related]
4. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
Yamamoto BK; Nash JF; Gudelsky GA
J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
[TBL] [Abstract][Full Text] [Related]
5. [Dopamine metabolism and the GABA level in the structures of the nigrostriatal and mesolimbic systems of the rat brain in experimental pathology of higher nervous activity].
Saul'skaia NB
Zh Vyssh Nerv Deiat Im I P Pavlova; 1988; 38(6):1145-51. PubMed ID: 3245325
[TBL] [Abstract][Full Text] [Related]
6. GABAergic attenuation of cocaine-induced dopamine release and locomotor activity.
Dewey SL; Chaurasia CS; Chen CE; Volkow ND; Clarkson FA; Porter SP; Straughter-Moore RM; Alexoff DL; Tedeschi D; Russo NB; Fowler JS; Brodie JD
Synapse; 1997 Apr; 25(4):393-8. PubMed ID: 9097399
[TBL] [Abstract][Full Text] [Related]
7. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
[TBL] [Abstract][Full Text] [Related]
8. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
[TBL] [Abstract][Full Text] [Related]
9. Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the rat.
Wood PL
J Pharmacol Exp Ther; 1982 Sep; 222(3):674-9. PubMed ID: 6286931
[TBL] [Abstract][Full Text] [Related]
10. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
Zeevalk GD; Manzino L; Sonsalla PK
Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
[TBL] [Abstract][Full Text] [Related]
11. Brain region effects of clozapine on amino acid and monoamine transmission.
Yamamoto BK; Pehek EA; Meltzer HY
J Clin Psychiatry; 1994 Sep; 55 Suppl B():8-14. PubMed ID: 7961581
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat.
Hernández LF; Segovia G; Mora F
Neurochem Int; 2008 Feb; 52(3):457-69. PubMed ID: 17881090
[TBL] [Abstract][Full Text] [Related]
13. Locomotor activity and speed of movements in relation to monoamine-acting drugs.
Hassler R; Wagner A
Int J Neurol; 1975; 10(1-4):80-97. PubMed ID: 126971
[No Abstract] [Full Text] [Related]
14. Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release.
Guyon A; Skrzydelski D; De Giry I; Rovère C; Conductier G; Trocello JM; Daugé V; Kitabgi P; Rostène W; Nahon JL; Mélik Parsadaniantz S
Neuroscience; 2009 Sep; 162(4):1072-80. PubMed ID: 19477239
[TBL] [Abstract][Full Text] [Related]
15. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
Lavoute C; Weiss M; Rostain JC
Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine.
Nowak P; Kostrzewa RM; Kwieciński A; Bortel A; Labus Ł; Brus R
J Physiol Pharmacol; 2005 Jun; 56(2):325-33. PubMed ID: 15985712
[TBL] [Abstract][Full Text] [Related]
17. The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system.
Skrzydelski D; Guyon A; Daugé V; Rovère C; Apartis E; Kitabgi P; Nahon JL; Rostène W; Parsadaniantz SM
J Neurochem; 2007 Aug; 102(4):1175-83. PubMed ID: 17509088
[TBL] [Abstract][Full Text] [Related]
18. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
Enna SJ; Reisman SA; Stanford JA
Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
[TBL] [Abstract][Full Text] [Related]
19. [Effects of pyrethroids on dopamine and its metabolites in nigrostriatum of male rats].
Liu GP; Shi N; Liang JH; Chen L
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Oct; 22(5):368-70. PubMed ID: 15555315
[TBL] [Abstract][Full Text] [Related]
20. Estradiol attenuates the K+-induced increase in extracellular GABA in rat striatum.
Hu M; Watson CJ; Kennedy RT; Becker JB
Synapse; 2006 Feb; 59(2):122-4. PubMed ID: 16320305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
